358 related articles for article (PubMed ID: 21872534)
1. Clinical and economic impact of vagus nerve stimulation therapy in patients with drug-resistant epilepsy.
Helmers SL; Duh MS; Guérin A; Sarda SP; Samuelson TM; Bunker MT; Olin BD; Jackson SD; Faught E
Epilepsy Behav; 2011 Oct; 22(2):370-5. PubMed ID: 21872534
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes, quality of life, and costs associated with implantation of vagus nerve stimulation therapy in pediatric patients with drug-resistant epilepsy.
Helmers SL; Duh MS; Guérin A; Sarda SP; Samuelson TM; Bunker MT; Olin BD; Jackson SD; Faught E
Eur J Paediatr Neurol; 2012 Sep; 16(5):449-58. PubMed ID: 22261080
[TBL] [Abstract][Full Text] [Related]
3. Impact of vagus nerve stimulation on secondary care burden in children and adults with epilepsy: Review of routinely collected hospital data in England.
Camp C; Smithson WH; Bunker M; Burke T; Hughes D
Epilepsy Behav; 2015 Nov; 52(Pt A):68-73. PubMed ID: 26409132
[TBL] [Abstract][Full Text] [Related]
4. Refractory epilepsy in tuberous sclerosis: vagus nerve stimulation with or without subsequent resective surgery.
Elliott RE; Carlson C; Kalhorn SP; Moshel YA; Weiner HL; Devinsky O; Doyle WK
Epilepsy Behav; 2009 Nov; 16(3):454-60. PubMed ID: 19767244
[TBL] [Abstract][Full Text] [Related]
5. Expected Budget Impact and Health Outcomes of Expanded Use of Vagus Nerve Stimulation Therapy for Drug-Resistant Epilepsy.
Purser MF; Mladsi DM; Beckman A; Barion F; Forsey J
Adv Ther; 2018 Oct; 35(10):1686-1696. PubMed ID: 30143957
[TBL] [Abstract][Full Text] [Related]
6. Vagus nerve stimulation therapy for pharmacoresistant epilepsy: effect on health care utilization.
Bernstein AL; Hess T
Epilepsy Behav; 2007 Feb; 10(1):134-7. PubMed ID: 17084676
[TBL] [Abstract][Full Text] [Related]
7. Vagus nerve stimulation therapy in a developing country: a long term follow up study and cost utility analysis.
Aburahma SK; Alzoubi FQ; Hammouri HM; Masri A
Seizure; 2015 Feb; 25():167-72. PubMed ID: 25468513
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of vagal nerve stimulation in children with pharmacoresistant epilepsy: practical experience at a Turkish tertiary referral center.
Arhan E; Serdaroglu A; Kurt G; Bilir E; Durdağ E; Erdem A; Aksakal FN; Ozcelik A; Baykaner K
Eur J Paediatr Neurol; 2010 Jul; 14(4):334-9. PubMed ID: 19850501
[TBL] [Abstract][Full Text] [Related]
9. Impact of failed intracranial epilepsy surgery on the effectiveness of subsequent vagus nerve stimulation.
Elliott RE; Morsi A; Geller EB; Carlson CC; Devinsky O; Doyle WK
Neurosurgery; 2011 Dec; 69(6):1210-7. PubMed ID: 21558973
[TBL] [Abstract][Full Text] [Related]
10. Vagus nerve stimulation for drug-resistant epilepsy: a European long-term study up to 24 months in 347 children.
Orosz I; McCormick D; Zamponi N; Varadkar S; Feucht M; Parain D; Griens R; Vallée L; Boon P; Rittey C; Jayewardene AK; Bunker M; Arzimanoglou A; Lagae L
Epilepsia; 2014 Oct; 55(10):1576-84. PubMed ID: 25231724
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of vagus nerve stimulation over time: review of 65 consecutive patients with treatment-resistant epilepsy treated with VNS > 10 years.
Elliott RE; Morsi A; Tanweer O; Grobelny B; Geller E; Carlson C; Devinsky O; Doyle WK
Epilepsy Behav; 2011 Mar; 20(3):478-83. PubMed ID: 21296622
[TBL] [Abstract][Full Text] [Related]
12. Vagus nerve stimulation in drug-resistant epilepsies. Analysis of potential prognostic factors in a cohort of patients with long-term follow-up.
Colicchio G; Montano N; Fuggetta F; Papacci F; Signorelli F; Meglio M
Acta Neurochir (Wien); 2012 Dec; 154(12):2237-40. PubMed ID: 23086106
[TBL] [Abstract][Full Text] [Related]
13. Vagus nerve stimulation therapy in patients with autism spectrum disorder and intractable epilepsy: results from the vagus nerve stimulation therapy patient outcome registry.
Levy ML; Levy KM; Hoff D; Amar AP; Park MS; Conklin JM; Baird L; Apuzzo ML
J Neurosurg Pediatr; 2010 Jun; 5(6):595-602. PubMed ID: 20515333
[TBL] [Abstract][Full Text] [Related]
14. Cumulative effect of vagus nerve stimulators on intractable seizures observed over a period of 3years.
Siddiqui F; Herial NA; Ali II
Epilepsy Behav; 2010 Jul; 18(3):299-302. PubMed ID: 20580901
[TBL] [Abstract][Full Text] [Related]
15. Treatment of drug-resistant epilepsy with vagus nerve stimulation -- review of 45 cases.
Bao M; Zhou J; Luan GM
Chin Med J (Engl); 2011 Dec; 124(24):4184-8. PubMed ID: 22340384
[TBL] [Abstract][Full Text] [Related]
16. VNS Therapy versus the latest antiepileptic drug.
Ben-Menachem E; French JA
Epileptic Disord; 2005 Sep; 7 Suppl 1():S22-6. PubMed ID: 16120490
[TBL] [Abstract][Full Text] [Related]
17. Vagus nerve stimulation for refractory epilepsy: a Belgian multicenter study.
De Herdt V; Boon P; Ceulemans B; Hauman H; Lagae L; Legros B; Sadzot B; Van Bogaert P; van Rijckevorsel K; Verhelst H; Vonck K
Eur J Paediatr Neurol; 2007 Sep; 11(5):261-9. PubMed ID: 17395507
[TBL] [Abstract][Full Text] [Related]
18. Cost-benefit of vagus nerve stimulation for refractory epilepsy.
Boon P; Vonck K; D'Have M; O'Connor S; Vandekerckhove T; De Reuck J
Acta Neurol Belg; 1999 Dec; 99(4):275-80. PubMed ID: 10674145
[TBL] [Abstract][Full Text] [Related]
19. Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study.
Faught RE; Weiner JR; Guérin A; Cunnington MC; Duh MS
Epilepsia; 2009 Mar; 50(3):501-9. PubMed ID: 19183224
[TBL] [Abstract][Full Text] [Related]
20. Vagus nerve stimulation for children with treatment-resistant epilepsy: a consecutive series of 141 cases.
Elliott RE; Rodgers SD; Bassani L; Morsi A; Geller EB; Carlson C; Devinsky O; Doyle WK
J Neurosurg Pediatr; 2011 May; 7(5):491-500. PubMed ID: 21529189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
